Skip to main content
HuBei NengTer Technology CO.,Ltd logo

HuBei NengTer Technology CO.,Ltd — Investor Relations & Filings

Ticker · 002102 ISIN · CNE000001Q28 Shenzhen Stock Exchange Manufacturing
Filings indexed 3,004 across all filing types
Latest filing 2020-04-15 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002102

About HuBei NengTer Technology CO.,Ltd

https://www.guanfu.com

HuBei NengTer Technology CO.,Ltd specializes in the research, development, and large-scale production of fine chemicals and pharmaceutical intermediates. The company is a prominent global supplier of key intermediates for Vitamin E, including trimethylhydroquinone and isophytol, utilizing proprietary catalytic technologies. Its product portfolio also encompasses high-end chiral chemicals and intermediates for cardiovascular medications, such as statins. HuBei NengTer focuses on technological innovation in chemical synthesis, aiming for high-efficiency and environmentally sustainable manufacturing processes. The company serves international markets, providing essential raw materials for the pharmaceutical, nutraceutical, and animal nutrition sectors.

Recent filings

Filing Released Lang Actions
关于公司监事会主席辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the chairman of the supervisory board of the company. It details the resignation, the legal implications, and the company's plan to elect a new supervisor. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2020-04-15 Chinese
关于与同孚实业私募债项目相关债权人签署和解协议书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company ST 冠福 (Guangfu Holdings Co., Ltd.) regarding the signing of settlement agreements related to a private placement bond project issued by a related party, 同孚实业 (Tongfu Industrial). It details the background of the debt dispute, the terms of the settlement agreements, the amounts involved, and the implications for the company's profits and risks. The document is structured as a formal announcement to shareholders and the public, providing detailed information about the settlement but does not contain financial statements or comprehensive financial analysis. It is not an annual or interim report, nor an earnings release or management discussion. It is also not a regulatory certification or a proxy statement. The document is a regulatory announcement about a legal and financial settlement event affecting the company, which fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2020-04-15 Chinese
关于控股股东新增被列入失信被执行人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's controlling shareholder being newly listed as a dishonest executor. It includes details about the legal case and references previous similar announcements. The document is short (1070 characters) and is a regulatory disclosure about a legal and compliance matter related to the controlling shareholder. It does not contain financial statements, audit information, or detailed management discussion. It is not a report or presentation but a regulatory announcement about a legal status update. Therefore, it fits best under Regulatory Filings (RNS).
2020-04-15 Chinese
关于公司持有子公司股权新增冻结的公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement by a company regarding the judicial freezing of its holdings in subsidiaries due to related litigation and guarantees provided for a private bond project that has defaulted. It details the frozen equity, the courts involved, the legal case numbers, and the impact on the company. There is no financial statement, earnings data, or management discussion of financial results. The document is a regulatory announcement about legal and operational risks and ongoing litigation, not a financial report, earnings release, or management report. It is not a notice of voting results, capital change, or share transactions. The document fits best as a Legal Proceedings Report (LTR) because it provides updates on significant lawsuits and legal matters involving the company.
2020-04-15 Chinese
关于争取撤销其他风险警示所采取的措施及有关工作进展情况的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from the company ST 冠福 (Guangfu Holdings Co., Ltd.) regarding measures taken to remove a risk warning related to the controlling shareholder's violations, including overdue debts, lawsuits, and financial restructuring efforts. It includes extensive litigation details, risk disclosures, and progress updates on resolving these issues. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report. It is not a call transcript, earnings release, or capital update. It is a regulatory announcement about ongoing legal and financial risk matters and company actions to address them. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2020-04-15 Chinese
独立董事关于全资子公司能特科技有限公司相关土地使用权及土地上附属物由政府收储的独立意见
Governance Information Classification · 95% confidence The document is an independent opinion from the independent directors of the company regarding a specific transaction involving the company's wholly-owned subsidiary and government land acquisition. It references compliance with company law, stock exchange listing rules, and company articles, and concludes with the independent directors' agreement on the fairness and legality of the transaction. The document is short (802 characters) and focuses on a specific governance and transaction matter rather than presenting financial data or a full report. It is not an annual report, audit report, earnings release, or any financial statement. It is also not a general regulatory filing or announcement of a report. The content aligns best with a Governance Information (CGR) filing, as it involves board-level independent director opinions on a corporate governance matter related to a transaction and compliance with laws and regulations.
2020-04-01 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.